{
    "laboratory_examinations": [
        {
            "procedure_name": "LPL activity measurement",
            "date": "Not specified",
            "findings": "LPL activity varied; intermittently mildly reduced like in heterozygous LPL deficiency or severely reduced as in homozygous LPL deficiency.",
            "changes_over_time": "Not specified."
        },
        {
            "procedure_name": "Plasma triglycerides measurement",
            "date": "Not specified",
            "findings": "Plasma triglyceride concentration was 25.9 mmol/liter (normal range: 0.5–2.0 mmol/liter).",
            "changes_over_time": "Under immunosuppressive treatment, plasma TG concentration decreased from an average of 27.0 mmol/liter to 17.7 mmol/liter (a 38% decrease)."
        },
        {
            "procedure_name": "Total plasma cholesterol measurement",
            "date": "Not specified",
            "findings": "Total cholesterol was 7.01 mmol/liter (normal range: 3.8–6.0 mmol/liter).",
            "changes_over_time": "Not specified."
        },
        {
            "procedure_name": "LDL-C and HDL-C measurement",
            "date": "Not specified",
            "findings": "LDL-C was 0.84 mmol/liter (normal range: 2.0–4.2 mmol/liter) and HDL-C was 0.20 mmol/liter (normal range: 1.05–1.8 mmol/liter).",
            "changes_over_time": "Not specified."
        },
        {
            "procedure_name": "Measurement of apolipoproteins",
            "date": "Not specified",
            "findings": "Apo B was 0.81 g/liter (normal range: 0.55–1.30 g/liter), Apo CII was 116 mg/dl (normal range: 21–47 mg/dl), and Apo CIII was 326 mg/dl (normal range: 60–120 mg/dl).",
            "changes_over_time": "Not specified."
        }
    ]
}